Free Trial
NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Price, News & Analysis

Trinity Biotech logo
$0.79 +0.01 (+1.54%)
Closing price 03:58 PM Eastern
Extended Trading
$0.76 -0.03 (-3.67%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Trinity Biotech Stock (NASDAQ:TRIB)

Key Stats

Today's Range
$0.72
$0.79
50-Day Range
$0.55
$0.85
52-Week Range
$0.48
$3.44
Volume
98,534 shs
Average Volume
1.11 million shs
Market Capitalization
$14.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Trinity Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

TRIB MarketRank™: 

Trinity Biotech scored higher than 21% of companies evaluated by MarketBeat, and ranked 898th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Trinity Biotech.

  • Earnings Growth

    Earnings for Trinity Biotech are expected to grow in the coming year, from ($1.51) to ($0.90) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Trinity Biotech is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Trinity Biotech is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Trinity Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    4.33% of the float of Trinity Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Trinity Biotech has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trinity Biotech has recently increased by 1,668.79%, indicating that investor sentiment is decreasing significantly.
  • Percentage of Shares Shorted

    4.33% of the float of Trinity Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Trinity Biotech has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trinity Biotech has recently increased by 1,668.79%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Trinity Biotech has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Trinity Biotech this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Trinity Biotech to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Trinity Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.20% of the stock of Trinity Biotech is held by insiders.

  • Percentage Held by Institutions

    78.97% of the stock of Trinity Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Trinity Biotech's insider trading history.
Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

TRIB Stock Analysis - Frequently Asked Questions

Trinity Biotech's stock was trading at $0.8802 on January 1st, 2025. Since then, TRIB stock has decreased by 10.2% and is now trading at $0.79.

Trinity Biotech PLC (NASDAQ:TRIB) released its quarterly earnings results on Monday, May, 24th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.35 by $0.15. The company had revenue of $25.59 million for the quarter.
Read the conference call transcript
.

Trinity Biotech shares reverse split before market open on Wednesday, February 21st 2024.The 1-5 reverse split was announced on Wednesday, February 21st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 21st 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trinity Biotech investors own include Bristol Myers Squibb (BMY), Micron Technology (MU), OPKO Health (OPK), Novavax (NVAX), Corbus Pharmaceuticals (CRBP), Gilead Sciences (GILD) and Pfizer (PFE).

Company Calendar

Last Earnings
5/24/2021
Today
7/11/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRIB
CIK
888721
Employees
480
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($2.93)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.79 million
Net Margins
-51.64%
Pretax Margin
-49.92%
Return on Equity
N/A
Return on Assets
-27.43%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.28
Quick Ratio
0.68

Sales & Book Value

Annual Sales
$61.56 million
Price / Sales
0.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.95) per share
Price / Book
-0.40

Miscellaneous

Outstanding Shares
18,054,000
Free Float
16,574,000
Market Cap
$14.05 million
Optionable
Optionable
Beta
0.80

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:TRIB) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners